Guthrie, Eshoo Raise Concerns on FDA Backlog of Cell and Gene Therapy Applications
March 29, 2023
March 29, 2023
WASHINGTON, March 29 -- Rep. S. Brett Guthrie, R-Kentucky, issued the following news release and letter:
Congressman Brett Guthrie (KY-02) and Congresswoman Anna Eshoo (CA-16), who serve as the Chair and Ranking Member, respectively, of the House Energy and Commerce Committee Subcommittee on Health, sent a letter to Dr. Peter Marks, the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA), on the backlog of cell and gene thera . . .
Congressman Brett Guthrie (KY-02) and Congresswoman Anna Eshoo (CA-16), who serve as the Chair and Ranking Member, respectively, of the House Energy and Commerce Committee Subcommittee on Health, sent a letter to Dr. Peter Marks, the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA), on the backlog of cell and gene thera . . .